Neoplasms

All Conditions

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Carcinoma

Uterine Neoplasms

Endometrial Neoplasms

Genital Neoplasms, Female

Urogenital Neoplasms

Uterine Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Antineoplastic Agents

All Drugs and Chemicals

Dactolisib

BEZ235

Novartis Pharmaceuticals

This is an open label and single arm study to investigate the safety and efficacy of BEZ235 in adult women with endometrial carcinoma whose disease progressed (or recurred) while on or after first-line antineoplastic treatment for advanced endometrial carcinoma.

BEZ235 Trial in Patients With Advanced Endometrial Carcinoma

A Phase II, Single-arm Study of Orally Administered BEZ235 as Second-line Therapy in Patients With Advanced or Metastatic Endometrial Carcinoma

BKM120

In this study, BKM120 will be administered to adult patients with advanced solid tumors whose disease has progressed despite standard therapy or for whom no standard therapy exists. The trial will confirm the safety and tolerability and determine the maximum tolerated dose (MTD) of BKM120 in Japanese patients.

A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors

A Phase I Study of BKM120, Administered Orally in Adult Japanese Patients With Advanced Solid Tumors

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
BEZ235 Trial in Patients With Advanced Endometrial Carcinoma	NCT01290406	Endometrial Can...	BEZ235	18 Years -	Novartis
A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors	NCT01283503	Advanced Solid ...	BKM120	20 Years -	Novartis
A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors	NCT01283503	Advanced Solid ...	BKM120	20 Years -	Novartis
BEZ235 Trial in Patients With Advanced Endometrial Carcinoma	NCT01290406	Endometrial Can...	BEZ235	18 Years -	Novartis

Spots Global Cancer Trial Database for pi3k,

Every month we try and update this database with for pi3k, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for pi3k,

Every month we try and update this database with for pi3k, cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for pi3k, cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.